Cipla's flagship respiratory initiative Breathefree broadens its footprint in the UAE
Equillium, Inc. (EQ)
Last equillium, inc. earnings: 3/26 04:07 pm
Check Earnings Report
Company Research
Source: PR Newswire
MUMBAI, India, Oct. 27, 2025 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced the launch of Breathefree UAE, the company's first patient awareness initiative in the Middle East. Building on the success of the company's flagship Breathefree program in India, this initiative marks Cipla's long-term commitment to advancing respiratory health in the region, starting with the UAE. Designed to support patients, doctors, and pharmacists, Breathefree UAE aims to create greater awareness and better management of respiratory conditions.As of 2025, the estimated asthma prevalence in the UAE is approximately 8.5%.1 A 2023 cross-sectional study in the UAE reported asthma prevalence of 11.9% in children aged 6–7 years and 9.8% in those aged 13–14 years.2 Allergic rhinitis affects 6.4% of adults in the Gulf region, including the UAE.3 The prevalence of COPD in the UAE is about 3.7 to 5.2%.4Against this backdrop, Breathefree UAE seeks to address the c
Show less
Read more
Impact Snapshot
Event Time:
EQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EQ alerts
High impacting Equillium, Inc. news events
Weekly update
A roundup of the hottest topics
EQ
News
- Equillium (NASDAQ:EQ) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Equillium to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Equillium to Participate in Upcoming Investor ConferencesGlobeNewswire
- Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript [Seeking Alpha]Seeking Alpha
- Equillium to Participate in Upcoming Investor ConferencesGlobeNewswire
EQ
Earnings
- 3/27/25 - Beat
EQ
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 144
- 11/14/25 - Form SCHEDULE
- EQ's page on the SEC website